Login
Home
Charts
Search
Watchlist
Products

Amerise Biosciences Ltd

AMERISE·BSE
0.81-3.57%Tue, 22 Sept '26 15:15

Amerise Biosciences Ltd

AMERISE
BSE
0.81
-3.57%
|Tue, 22 Sept '26 15:15
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
5Cr
Close
Close Price
0.81
Industry
Industry
Miscellaneous
PE
Price To Earnings
PS
Price To Sales
28.17
Revenue
Revenue
0Cr
Rev Gr TTM
Revenue Growth TTM
-24.00%
PAT Gr TTM
PAT Growth TTM
-200.00%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
375.0-57.9-100.0
Expenses
ExpensesCr
000000000000
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
50.057.9-16.7-57.10.075.0
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
-300.0-20.0200.028.625.066.7450.080.0-33.3150.0-45.5-700.0
NPM
NPM%
50.057.9-16.7-57.125.075.0
EPS
EPS
0.00.00.00.00.00.00.00.00.00.00.00.0
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
375.0-57.9-100.0
Expenses
ExpensesCr
000000000000
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
50.057.9-16.7-57.10.075.0
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
-300.0-20.0200.028.625.066.7450.080.0-33.3150.0-45.5-700.0
NPM
NPM%
50.057.9-16.7-57.125.075.0
EPS
EPS
0.00.00.00.00.00.00.00.00.00.00.00.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
000100900000
Growth
Revenue Growth%
-100.0-100.0-24.0
Expenses
ExpensesCr
010100900000
Operating Profit
Operating ProfitCr
0-10000000000
OPM
OPM%
0.3-0.211.5-31.6
Other Income
Other IncomeCr
00000010000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
0-10000100000
Tax
TaxCr
000000000000
PAT
PATCr
0-10000100000
Growth
PAT Growth%
40.3-3,239.797.7119.4-3,725.2-126.2262.9-121.7-22.9103.9250.9-200.0
NPM
NPM%
0.36.17.7-26.3
EPS
EPS
0.0-1.40.00.00.0-0.10.10.00.00.00.00.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
000100900000
Growth
Revenue Growth%
-100.0-100.0-24.0
Expenses
ExpensesCr
010100900000
Operating Profit
Operating ProfitCr
0-10000000000
OPM
OPM%
0.3-0.211.5-31.6
Other Income
Other IncomeCr
00000010000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
0-10000100000
Tax
TaxCr
000000000000
PAT
PATCr
0-10000100000
Growth
PAT Growth%
40.3-3,239.797.7119.4-3,725.2-126.2262.9-121.7-22.9103.9250.9-200.0
NPM
NPM%
0.36.17.7-26.3
EPS
EPS
0.0-1.40.00.00.0-0.10.10.00.00.00.00.0

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
77777777777
Reserves
ReservesCr
0-1-1-1-1-2-1-1-1-1-1
Current Liabilities
Current LiabilitiesCr
00001160032
Non Current Liabilities
Non Current LiabilitiesCr
00000000000
Total Liabilities
Total LiabilitiesCr
766666126587
Current Assets
Current AssetsCr
03340060001
Non Current Assets
Non Current AssetsCr
63316666587
Total Assets
Total AssetsCr
766666126587
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
77777777777
Reserves
ReservesCr
0-1-1-1-1-2-1-1-1-1-1
Current Liabilities
Current LiabilitiesCr
00001160032
Non Current Liabilities
Non Current LiabilitiesCr
00000000000
Total Liabilities
Total LiabilitiesCr
766666126587
Current Assets
Current AssetsCr
03340060001
Non Current Assets
Non Current AssetsCr
63316666587
Total Assets
Total AssetsCr
766666126587

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-40-2500003-1
Investing Cash Flow
Investing Cash FlowCr
0402-50000-32
Financing Cash Flow
Financing Cash FlowCr
00000000000
Net Cash Flow
Net Cash FlowCr
00000000001
Free Cash Flow
Free Cash FlowCr
0-40-2500003-1
CFO To PAT
CFO To PAT%
0.0379.4207.1-43,286.6-3,282.9117.011.2111.1116.053,873.7-5,283.5
CFO To EBITDA
CFO To EBITDA%
0.0379.4207.1-43,286.6-3,270.4234.6-310.1103.593.2-1,704.1-3,522.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-40-2500003-1
Investing Cash Flow
Investing Cash FlowCr
0402-50000-32
Financing Cash Flow
Financing Cash FlowCr
00000000000
Net Cash Flow
Net Cash FlowCr
00000000001
Free Cash Flow
Free Cash FlowCr
0-40-2500003-1
CFO To PAT
CFO To PAT%
0.0379.4207.1-43,286.6-3,282.9117.011.2111.1116.053,873.7-5,283.5
CFO To EBITDA
CFO To EBITDA%
0.0379.4207.1-43,286.6-3,270.4234.6-310.1103.593.2-1,704.1-3,522.3

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
6511954645
Price To Earnings
Price To Earnings
17.0
Price To Sales
Price To Sales
0.9462.0109.028.2
Price To Book
Price To Book
1.11.02.11.60.80.81.10.71.0
EV To EBITDA
EV To EBITDA
-6.6-36.0-64.7-457.6-36.8-23.9-33.2110.3-82.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
1.51.0
OPM
OPM%
0.3-0.211.5-31.6
NPM
NPM%
0.36.17.7-26.3
ROCE
ROCE%
-0.4-16.8-0.40.1-2.8-6.69.6-2.1-2.70.10.40.4
ROE
ROE%
-0.4-16.8-0.40.1-2.8-6.69.7-2.1-2.70.10.40.4
ROA
ROA%
-0.4-16.7-0.40.1-2.5-6.04.6-2.1-2.70.10.30.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
6511954645
Price To Earnings
Price To Earnings
17.0
Price To Sales
Price To Sales
0.9462.0109.028.2
Price To Book
Price To Book
1.11.02.11.60.80.81.10.71.0
EV To EBITDA
EV To EBITDA
-6.6-36.0-64.7-457.6-36.8-23.9-33.2110.3-82.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
1.51.0
OPM
OPM%
0.3-0.211.5-31.6
NPM
NPM%
0.36.17.7-26.3
ROCE
ROCE%
-0.4-16.8-0.40.1-2.8-6.69.6-2.1-2.70.10.40.4
ROE
ROE%
-0.4-16.8-0.40.1-2.8-6.69.7-2.1-2.70.10.40.4
ROA
ROA%
-0.4-16.7-0.40.1-2.5-6.04.6-2.1-2.70.10.30.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Amerise Biosciences Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/ieokq0j9z6bw7rl9xo6ert1h.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/9tsm2z9f9pdi9noax1z5bl75.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/39ua7in2xfabvx8gshmjejf3.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/ks7us2eeierbwm68eki3wf5k.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/fg3597j1g8pbywyu542hvapq.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/3lopwt8pwpsbhvg9qpt7cesp.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/s5wl0iqw7ul6o5f2yo1roess.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/27rhg3797tbhqm3q39fnuueb.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/xk6jxy6rkka4gjrm2zowytjm.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/sy8lw212wgc18iyw01lzwixk.pdf